切换至 "中华医学电子期刊资源库"

中华移植杂志(电子版) ›› 2020, Vol. 14 ›› Issue (02) : 92 -95. doi: 10.3877/cma.j.issn.1674-3903.2020.02.007

所属专题: 文献

论著

心脏死亡器官捐献肝移植术后并发急性肾损伤危险因素分析
向丽1, 卢长江2, 胡杨科1, 吴胜东2, 陆才德2,()   
  1. 1. 315000 宁波大学医学院
    2. 315000 宁波市医疗中心李惠利医院肝胆胰外科
  • 收稿日期:2019-09-17 出版日期:2020-04-25
  • 通信作者: 陆才德
  • 基金资助:
    宁波市医学科技计划项目(2016A14); 宁波市科技创新团队(2013B82010); 宁波市医疗卫生品牌学科(PPXK2018-03)

Analysis of risk factors for acute kidney injury after donation after cardiac death liver transplantation

li Xiang1, Changjiang Lu2, Yangke Hu1, Shengdong Wu2, Caide Lu2,()   

  1. 1. Medical College of Ningbo University, Ningbo 315000, China
    2. Department of Hepatobiliary and Pancreatic Surgery, Li Huili Hospital, Ningbo Medical Center, Ningbo 315000, China
  • Received:2019-09-17 Published:2020-04-25
  • Corresponding author: Caide Lu
  • About author:
    Corresponding author: Lu Caide, Email:
引用本文:

向丽, 卢长江, 胡杨科, 吴胜东, 陆才德. 心脏死亡器官捐献肝移植术后并发急性肾损伤危险因素分析[J/OL]. 中华移植杂志(电子版), 2020, 14(02): 92-95.

li Xiang, Changjiang Lu, Yangke Hu, Shengdong Wu, Caide Lu. Analysis of risk factors for acute kidney injury after donation after cardiac death liver transplantation[J/OL]. Chinese Journal of Transplantation(Electronic Edition), 2020, 14(02): 92-95.

目的

探讨心脏死亡器官捐献(DCD)肝移植术后并发急性肾损伤(AKI)的危险因素。

方法

回顾性分析2012年1月至2018年11月宁波市医疗中心李惠利医院肝胆胰外科159例DCD肝移植受者临床资料,根据改善全球肾脏病预后组织临床实践指南中AKI诊断标准将159例受者分为AKI组(34例)和对照组(125例)。采用两独立样本t检验比较两组受者年龄和术前血清白蛋白。采用Wilcoxon符号秩和检验比较两组受者术前终末期肝病模型(MELD)评分、术前体质指数(BMI)、供肝冷/热缺血时间、术中输液量、术中出血量、术中输血量、术中尿量、手术时间、术中去甲肾上腺素总用量及总住院天数。采用卡方检验比较两组受者性别、术前乙型肝炎、术中低血压、术后感染、肝移植术式及术后再次手术情况。将单因素分析中有统计学差异的变量纳入Logistic回归进行多因素分析。P<0.05为差异有统计学意义。

结果

肝移植术后AKI发生率为21.4%(34/159)。单因素分析结果表明,AKI组与对照组受者术前MELD评分、术前血清白蛋白、术中输液量、术中出血量、术中尿量、手术时间、术中低血压及术后再次手术差异均有统计学意义(Z=2.763, t=-2.250, Z=2.040, Z=2.092, Z=-3.303, Z=-2.170, χ2=8.227, χ2=5.294, P均<0.05)。Logistic回归多因素分析结果显示:术前MELD评分、术前血清白蛋白、术中尿量和手术时间是DCD肝移植术后并发AKI的独立危险因素,差异均有统计学意义(P均<0.05)。

结论

DCD肝移植术前应改善受者一般情况,提高围手术期营养水平,术中控制液体出入量,合理使用利尿剂和缩短手术时间,以降低受者术后AKI发生率。

Objective

To explore the risk factors of acute kidney injury (AKI) after donation after cardiac death (DCD) liver transplantation.

Methods

A retrospective analysis of clinical data of 159 DCD liver transplant recipients from the Department of Hepatobiliary and Pancreatic Surgery at Li Huili Hospital of Ningbo Medical Center from January 2012 to November 2018 was performed. The recipients were divided into AKI group (34 cases) and control group (125 cases) according to the criteria of Kidney Disease: Improving Global Outcomes. Two independent sample t test was used to compare the age and serum albumin before transplantation of the 2 groups. Wilcoxon signed rank sum test was used to compare the preoperative model for end-stage liver disease (MELD) score, preoperative body mass index (BMI), donor liver cold/warm ischemic time, intraoperative infusion volume, intraoperative bleeding volume, and intraoperative intermediate blood transfusion, intraoperative urine output, operation time, total intraoperative norepinephrine dosage and total hospital stay. Chi-square test was used to compare the gender, preoperative hepatitis B, intraoperative hypotension, postoperative infection, liver transplantation method and postoperative reoperation. The variables with statistical difference in univariate analysis were included in Logistic regression for multivariate analysis. P<0.05 was considered statistically significant.

Results

The incidence of AKI after liver transplantation was 21.4% (34/159). Univariate analysis showed that the indexes including the preoperative MELD score, preoperative serum albumin, intraoperative infusion volume, intraoperative blood loss, intraoperative urine volume, surgical time, intraoperative hypotension and postoperative reoperation between the 2 groups had statistical significance (Z=2.763, t=-2.250, Z=2.040, Z=2.092, Z=-3.303, Z=-2.170, χ2=8.227, χ2=5.294, P all <0.05). Logistic regression multivariate analysis showed the indexes including the preoperative MELD score, preoperative serum albumin, intraoperative urine volume and operation time were independent risk factors for AKI after DCD liver transplantation, and the differences were statistically significant (P all<0.05).

Conclusions

For DCD liver transplantation, the general condition of the recipient before transplantation and the nutritional level during the perioperative period should be improved, and the amount of fluid should be controlled during the operation, the use of diuretics and the operation time should be shortened to reduce the incidence of AKI after transplantation.

表1 DCD肝移植术后并发AKI危险因素单因素分析结果
组别 例数 性别(男/女,例) 年龄(±s,岁) 术前MELD评分[M(MinMax),分] 术前血清白蛋白(±s,g/L)
AKI组 34 25/ 9 54±9 16(6,41) 39±9
对照组 125 103/22 52±9 12(6,37) 36±7
χ2/Z/t 1.340 -1.23 2.763 -2.250
P >0.05 >0.05 <0.05 <0.05
组别 例数 BMI[M(MinMax),kg/m2] 术前乙型肝炎(是/否,例) 供肝冷缺血时间[M(MinMax),h] 供肝热缺血时间[M(MinMax),min]
AKI组 34 23(17,35) 27/ 7 6.2(3.0,18.0) 10(5,19)
对照组 125 23(16,31) 92/33 6.5(2.5,15.5) 10(3,28)
χ2/Z/t 0.029 0.480 -0.175 0.266
P >0.05 >0.05 >0.05 >0.05
组别 例数 术中输液量[M(MinMax),mL] 术中出血量[M(MinMax),mL] 术中输血量[M(MinMax),mL] 术中尿量[M(MinMax),mL]
AKI组 34 6 535(1 680,21 090) 2 000(300,15 000) 2 800(0,12 430) 1 040(100,3 300)
对照组 125 5 345(1 200,25 600) 1 500(200, 9 000) 1 700(0,15 000) 1 625(425,4 100)
χ2/Z/t 2.040 2.092 -2.443 -3.303
P <0.05 <0.05 >0.05 <0.05
组别 例数 手术时间[M(MinMax),min] 去甲肾上腺素总用量[M(MinMax),mg] 术中低血压(有/无,例) 术后感染(有/无,例)
AKI组 34 360(260,650) 110(0,1 203) 23/11 15/19
对照组 125 420(240,810) 149(0,1 643) 50/75 38/87
χ2/Z/t -2.170 -0.555 8.227 2.263
P <0.05 >0.05 <0.05 >0.05
组别 例数 肝移植术式(经典/背驮式,例) 术后再次手术(有/无,例) 总住院天数[M(MinMax),d]
AKI组 34 11/23 7/ 27 24(11,60)
对照组 125 31/94 9/116 25( 7,62)
χ2/Z/t 0.784 5.294 -0.842
P >0.05 <0.05 >0.05
表2 DCD肝移植术后并发AKI危险因素多因素分析结果
[1]
Kellum JA, Lameire N, Aspelin P, et al. Kidney Disease: Improving Global Outcomes (KDIGO) Acute Kidney Injury Work Group. KDIGO clinical practice guideline for acute kidney injury[J]. Kidney international supplements, 2012, 2(1): 1-138.
[2]
Rossi AP, Vella JP. Acute kidney disease after liver and heart transplantation[J]. Transplantation, 2016,100(3): 506-514.
[3]
Leithead JA, Tariciotti L, Gunson B, et al. Donation after cardiac death liver transplant recipients have an increased frequency of acute kidney injury[J]. Am J Transplant, 2012, 12(4): 965-975.
[4]
Hilmi IA, Damian D, Al-Khafaji A, et al. Acute kidney injury following orthotopic liver transplantation: incidence, risk factors, and effects on patient and graft outcomes[J]. Br J Anaesth, 2015, 114(6):919-926.
[5]
Yin ZY, Li BF, Zou FN, et al. Risk factors of acute kidney injury after orthotopic liver transplantation in China[J]. Sci Rep,2017,7:41555.
[6]
吕海金,易述红,陈艳,等. 肝移植术后急性肾损伤的危险因素分析[J/CD]. 中华肝脏外科手术学电子杂志,2013, 2(5):310-313.
[7]
郑树森,沈恬,徐骁,等. 中国肝移植受者肾损伤管理专家共识(2017版)[J/CD]. 中华移植杂志:电子版,2017, 11(3): 130-137.
[8]
Romano TG, Schmidtbauer I, Silva FM, et al. Role of MELD score and serum creatinine as prognostic tools for the development of acute kidney injury after liver transplantation[J]. PLoS One, 2013, 8(5): e64089.
[9]
陈鸣,钱雅君,郭晓芳,等. 肝移植后早期急性肾损伤的临床特点[J]. 中华器官移植杂志,2017, 38(10): 589-593.
[10]
Park MH, Shim HS, Kim WH, et al. Clinical risk scoring models for prediction of acute kidney Injury after living donor liver transplantation: a retrospective observational study[J]. PloS One, 2015, 10(8): e0136230.
[11]
张春,林婷,张靖垚,等. 原位肝移植术后急性肾损伤发生的危险因素分析[J]. 中华消化外科杂志,2018, 17(5): 488-496.
[12]
Kalisvaart M, De Haan JE, Hesselink DA, et al. The postreperfusion syndrome is associated with acute kidney injury following donation after brain death liver transplantation[J]. Transpl Int, 2017, 30(7): 660-669.
[13]
Han SJ, Jang HS, Seu SY, et al. Hepatic ischemia/reperfusion injury disrupts the homeostasis of kidney primary cilia via oxidative stress[J]. Biochim Biophys Acta Mol Basis Dis, 2017, 1863(7): 1817-1828.
[14]
Chen J, Singhapricha T, Hu KQ, et al. Postliver transplant acute renal injury and failure by the RIFLE criteria in patients with normal pretransplant serum creatinine concentrations: a matched study[J]. Transplantation, 2011, 91(3): 348.
[15]
D′Alessandro A, Nemkov T, Kelher M, et al. Routine storage of red blood cell (RBC) units in additive solution-3: a comprehensive investigation of the RBC metabolome[J]. Transfusion, 2015, 55(6):1155-1168.
[1] 贺斌, 马晋峰. 胃癌脾门淋巴结转移危险因素[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 694-699.
[2] 仲福顺, 余露, 范晓礼, 叶啟发. 肝移植治疗肝上皮样血管内皮瘤一例[J/OL]. 中华移植杂志(电子版), 2024, 18(05): 293-297.
[3] 刘冉佳, 崔向丽, 周效竹, 曲伟, 朱志军. 儿童肝移植受者健康相关生存质量评价的荟萃分析[J/OL]. 中华移植杂志(电子版), 2024, 18(05): 302-309.
[4] 贺健, 张骊, 王洪海, 蒋文涛. 肝移植术后脾功能亢进转归及治疗研究进展[J/OL]. 中华移植杂志(电子版), 2024, 18(05): 310-314.
[5] 林凯, 潘勇, 赵高平, 杨春. 造口还纳术后切口疝的危险因素分析与预防策略[J/OL]. 中华疝和腹壁外科杂志(电子版), 2024, 18(06): 634-638.
[6] 杨闯, 马雪. 腹壁疝术后感染的危险因素分析[J/OL]. 中华疝和腹壁外科杂志(电子版), 2024, 18(06): 693-696.
[7] 傅斌生, 冯啸, 杨卿, 曾凯宁, 姚嘉, 唐晖, 刘剑戎, 魏绪霞, 易慧敏, 易述红, 陈规划, 杨扬. 脂肪变性供肝在成人劈离式肝移植中的应用[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 789-794.
[8] 魏志鸿, 刘建勇, 吴小雅, 杨芳, 吕立志, 江艺, 蔡秋程. 肝移植术后急性移植物抗宿主病的诊治(附四例报告)[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 846-851.
[9] 中华医学会器官移植学分会. 肝移植术后缺血性胆道病变诊断与治疗中国实践指南[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 739-748.
[10] 中华医学会器官移植学分会, 中华医学会外科学分会外科手术学学组, 中华医学会外科学分会移植学组, 华南劈离式肝移植联盟. 劈离式供肝儿童肝移植中国临床操作指南[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(05): 593-601.
[11] 刘军, 丘文静, 孙方昊, 李松盈, 易述红, 傅斌生, 杨扬, 罗慧. 在体与离体劈离式肝移植在儿童肝移植中的应用比较[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(05): 688-693.
[12] 司楠, 孙洪涛. 创伤性脑损伤后肾功能障碍危险因素的研究进展[J/OL]. 中华脑科疾病与康复杂志(电子版), 2024, 14(05): 300-305.
[13] 沈炎, 张俊峰, 唐春芳. 预后营养指数结合血清降钙素原、胱抑素C及视黄醇结合蛋白对急性胰腺炎并发急性肾损伤的预测价值[J/OL]. 中华消化病与影像杂志(电子版), 2024, 14(06): 536-540.
[14] 颜世锐, 熊辉. 感染性心内膜炎合并急性肾损伤患者的危险因素探索及死亡风险预测[J/OL]. 中华临床医师杂志(电子版), 2024, 18(07): 618-624.
[15] 李文哲, 王毅, 崔建, 郑启航, 王靖彦, 于湘友. 新疆维吾尔自治区重症患者急性肾功能异常的危险因素分析[J/OL]. 中华卫生应急电子杂志, 2024, 10(05): 269-276.
阅读次数
全文


摘要


AI


AI小编
你好!我是《中华医学电子期刊资源库》AI小编,有什么可以帮您的吗?